Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

While researchers continue to work on a full cure for Alzheimer's disease, they're finding treatments that can help manage ...

A new study found that some medications could have the unintended benefit of reducing dementia risk, while others could increase the risk. A doctor comments on the findings.

There has been progress. The latest Alzheimer’s drug appears to tackle the characteristic features of the disease in the ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

There are now two fully approved drugs on the market that can, sometimes, slow down the progression of Alzheimer's disease. Both have been shown... Two patients navigate the new Alzheimer's drugs ...

diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease. Antioxidants , 2025; 14 (3): 293 ...

St. Charles, Missouri, resident Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.

Heidi McWilliams, a 10-year Palm Beach resident, is chair of the organization's inaugural event at the Palm Beach County ...

A small study suggests that a type of medication called senolytics may help improve brain function in older adults at risk of ...